이동원

이동원 (chief executive) discloses dealings in 오스테오닉 to DART (FSS). Between 8 March 2021 and 4 September 2026, the trades on record add up to 73 filings.

On the open market, the record shows 4 purchases and 3 sales. No amount is published for 7 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 2 purchases and 1 sale.

Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 4 September 2026, the filings show a transaction in 오스테오닉. The clock since the last published purchase (12 January 2026) now reads 279 days. Filings reach the DART (FSS) feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.